nccn guidelines for patients with castration-resistant metastatic prostate cancer
Published 11 years ago • 561 plays • Length 2:29Download video MP4
Download video MP3
Similar videos
-
52:29
making sense of the nccn guidelines and other evidence for castrate resistant prostate cancer
-
1:34
nccn guidelines for genetic testing in prostate cancer
-
3:38
the nccn and aua guidelines for treating nmcrpc
-
7:52
nccn and aua prostate cancer guidelines
-
4:06
changes in nccn guideline: affecting first-line
-
7:50
nccn guidelines for treatment of localized prostate cancer
-
6:00
immunotherapy for castration-resistant prostate cancer
-
6:16
evolution of treatment for metastatic castration-resistant prostate cancer
-
8:14
case study: treating asymptomatic metastatic castration-resistant prostate cancer
-
6:59
prechemotherapy treatment strategies in castration-resistant prostate cancer
-
0:36
treating patients with progressive metastatic castration-resistant prostate cancer
-
15:51
early detection of metastatic castration-resistant prostate cancer
-
3:59
nccn guidelines for hr her2 metastatic breast cancer
-
3:46
changes in nccn guideline: affecting second-line
-
8:10
case study: managing minimally symptomatic metastatic castration-resistant prostate cancer
-
6:42
immunotherapy in castration-resistant prostate cancer, part i
-
1:24:18
nccn patient webinar: early stage prostate cancer
-
7:07
treatment landscape of castrate-resistant prostate cancer
-
2:10
current standards for first-line metastatic hormone-sensitive prostate cancer